-
1h 12m 7s
-
36m 57s
-
51m 18s
-
52m 44s
-
58m 38s
-
1h 27m
Presentations
- Risk Stratification & Prognostic Assessment
- The General Approach to Management
- Management of Our Case Study: Hypertrophic Cardiomyopathy Patient
Radcliffe Cardiology was proud to host New Horizons in Cardiomyopathy 2025 (NHC), specially focused on cardiac amyloidosis and cardiomyopathy diagnosis and treatment.
Day 1 focused on hypertrophic cardiomyopathy (HCM), with a detailed exploration of HCM and an emphasis on emerging therapies and management strategies. Day 2 focused on amyloidosis, providing a comprehensive update on the diagnosis and treatment of cardiac amyloidosis, along with insights into the latest research and clinical practices.
The course directors, Prof Rodney Falk (Brigham and Women’s Hospital, US), Prof Perry Elliott (University College London, UK), and Prof Marianna Fontana (University College London, UK), led a distinguished group of faculty members who are renowned experts in the field of cardiac amyloidosis and HCM.
NHC was designed to educate healthcare professionals on the evolving management practices in cardiac amyloidosis and cardiomyopathy in an informal and engaging learning environment featuring thought-provoking presentations, cases and practical masterclasses.
*Please note, the live version of New Horizons in Cardiomyopathy was accredited. The on-demand version is not.
Learning Objectives
- Increase the awareness of at-risk patients
- Improve understanding of screening procedures
- Provide guidance on the use of imaging for diagnosis
- Improve awareness on current and emerging treatment
- Provide guidance on initiating treatment and managing comorbidities
Target Audience
- Cardiologists (device implanters, heart failure)
- Imaging Specialists
- Electrophysiologists
- Primary Care
- Haematologists
- Cardiac Nurse Practitioners
More from this programme
Part 1
Day 1: Session 1 – The Cardiomyopathy Mindset
In this opening session of NHC, presentations cover the basics of cardiomyopathy diagnosis, including when to suspect it and overview of the diagnostic pathway. The faculty present on clinical indicators for suspicion and discuss case studies.
Part 2
Day 1: Session 2 – The Diagnostic Pathway
Session 2 focuses on the diagnostic pathway. Faculty discuss assessing the ventricular function in the diagnosis of cardiomyopathy, diagnostic tools and phenotyping.
| 1 session | |
| Watch now |
Part 3
Day 1: Session 3 – The Management of Cardiomyopathy
This session highlights the critical role of risk stratification and prognostic assessment in the management of hypertrophic cardiomyopathy. The discussion also delves into the management strategies tailored to hypertrophic cardiomyopathy patients through a case study approach.
Part 4
Day 2: Session 1 – Amyloidosis Specific Diagnosis
This session covers amyloidosis diagnosis, featuring a case study on key clinical clues. It explores scintigraphy challenges and CMR imaging's role in cardiac amyloidosis.
Part 5
Day 2: Session 2 – Implementation in Practice
The faculty dive into a complex case, examining the challenges of both diagnosing and managing a patient, providing valuable insights into navigating such multifaceted scenarios.
Part 6
Day 2: Session 3 – Phenotyping Management Strategies
This session focuses on phenotyping management strategies for amyloidosis. The faculty discuss collaborating with haematologists to address cardiac complexities and complications that arise during chemotherapy.
Part 7
Day 2: Session 4 – The Treatment Horizon
In the final session of the event, faculty provide an overview of recently completed and on-going trials.
| 1 session | |
| Watch now |
Faculty Biographies
Perry Elliott
Professor in Inherited Cardiovascular Disease
Personal History
Professor Perry Mark Elliott was born on December 7, 1963, in London.6 He is a Professor of Cardiovascular Medicine at University College London (UCL) and a Senior Investigator of the UK National Institute for Health Research (NIHR).
He is Director of the UCL Centre for Heart Muscle Disease, Head of Clinical Research at the Institute of Cardiovascular Science UCL and a consultant cardiologist in the Centre for Inherited Cardiovascular Disease at the Barts Heart Centre, St. Bartholomew's Hospital London, UK.3
Academic History1
Dr Elliott studied medicine at St. Thomas’s Hospital Medical School, London from 1982 to 1987.
After graduating in 1987 he trained in general medicine. In 1991 he became a member of the Royal College of Physicians and completed his general cardiology training at St. George’s Hospital Medical School, London.
His…
Rodney Falk
Associate Professor
Dr Rodney Falk is a prominent figure in the field of cardiology, holding the esteemed position of director for the Cardiac Amyloidosis Program and serving as a specialist in cardiovascular medicine at Brigham and Women's Hospital (BWH). In addition, he is an associate professor of medicine at Harvard Medical School, reflecting his involvement in both clinical practice and academia.
Dr Falk's academic journey commenced with the acquisition of his medical degree from the University of Birmingham Medical School in the United Kingdom. His rigorous training encompasses a trio of residencies: one in internal medicine at Brook General Hospital, another in internal medicine at City Hospital, and a cardiology program at King's College Hospital, all situated in London, UK. Complementing his extensive background, he furthered his expertise with a cardiology fellowship at Harvard School of Public Health, emphasizing his dedication to continued learning and…
Elena Arbelo
Associate Professor
Prof Elena Arbelo is a Cardiac Electrophysiologist at Hospital Clínic of Barcelona, Barcelona, Spain, where she serves as Coordinator of the Cardiac Genetic Diseases and Sudden Arrhythmic Death Unit.
She is a Clinical Professor at the University of Barcelona and a researcher at the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). Prof Arbelo is a member of several committees of the European Society of Cardiology (ESC), the European Heart Rhythm Association (EHRA), and the Heart Rhythm Society (HRS).
Prof Arbelo is a committee member for several large-scale European Registries to gather data on atrial fibrillation and guideline implementation. She serves as a member of the Working Group on Atrial Fibrillation of the International Consortium for Health Outcomes Measurement (ICHOM).
Prof Arbelo is an editorial board member of Arrhythmia & Electrophysiology Review journal.
Ahmad Masri
Dr Ahmad Masri M.D., M.S. trained in Internal Medicine at the Cleveland Clinic.
He specialises in caring for patients with conditions that result in abnormally thickened hearts, such as hypertrophic cardiomyopathy, amyloidosis and Fabry’s disease.
Jacob Tfelt-Hansen
Consultant Cardiologist
Prof Jacob Tfelt-Hansen is a Consultant Cardiologist at Copenhagen University Hospital, Copenhagen, DK.
Prof Tfelt-Hansen specialises in sudden cardiac death, inherited heart diseases and intracardiac devices.